A newly discovered type of genetic mutation that occurs frequently in cancer cells may provide clues about the disease’s origins and offer new therapeutic targets, according to new research from Weill Cornell Medicine and the New York Genome Center. Using next-generation sequencing technology, scientists have previously traced cancer’s roots to mutations that disrupt the sequence […]
The New York Genome Center (NYGC) welcomes Marcin Imielinski, MD, PhD, as a Core Member, Assistant Investigator, where he will develop computational algorithms and apply cutting-edge sequencing technologies to study cancer genome structure. His group will work closely with both the NYGC Bioinformatics team and the Innovation Lab to push forward novel approaches for detecting […]
